Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: DSLT for Reducing Medication in Glaucoma

View source ↗

Summary

Clinical trial update indicates a study evaluating DSLT to reduce glaucoma medications is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DSLT

Snippet

Sponsor: The Eye Institute of West Florida | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Status: RECRUITING